IE
FLXN

Israel Englander’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Israel Englander’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-70,600
Closed -$1.82M – 4432
2018
Q2 		$1.82M Buy
+70,600
New +$1.83M ﹤0.01% 2467

Israel Englander's FLXN Position: Q4 2021 in Review

Israel Englander sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 777,952 shares — an estimated $4.75M sold.

Israel Englander first reported a position in FLXN in Q1 2015 and held it in 15 quarters. The position peaked at $15.5M in Q1 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • Israel Englander reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Israel Englander sold 777,952 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $4.75M.
  • Israel Englander first reported a position in Flexion Therapeutics, Inc. in Q1 2015 and held it in 15 quarters.
  • Israel Englander's Flexion Therapeutics, Inc. position peaked at $15.5M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.